School of Medicine Publications and Presentations
Document Type
Article
Publication Date
4-20-2021
Abstract
The COVID-19 pandemic has devastated individuals, families, and institutions throughout the world. Despite the breakneck speed of vaccine development, the human population remains at risk of further devastation. The decision to not become vaccinated, the protracted rollout of available vaccine, vaccine failure, mutational forms of the SARS virus, which may exhibit mounting resistance to our molecular strike at only one form of the viral family, and the rapid ability of the virus(es) to hitch a ride on our global transportation systems, means that we are will likely continue to confront an invisible, yet devastating foe. The enemy targets one of our human physiology’s most important and vulnerable life-preserving body tissues, our broncho-alveolar gas exchange apparatus.
Notwithstanding the fear and the fury of this microbe's potential to raise existential questions across the entire spectrum of human endeavor, the application of an early treatment intervention initiative may represent a crucial tool in our defensive strategy. This strategy is driven by evidence-based medical practice principles, those not likely to become antiquated, given the molecular diversity and mutational evolution of this very clever “world traveler”
Recommended Citation
Frohman, E. M., Villemarette-Pittman, N. R., Rodriguez, A., Glanzman, R., Rugheimer, S., Komogortsev, O., Zamvil, S. S., Cruz, R. A., Varkey, T. C., Frohman, A. N., Frohman, A. R., Parsons, M. S., Konkle, E. H., & Frohman, T. C. (2021). Application of an evidence-based, out-patient treatment strategy for COVID-19: Multidisciplinary medical practice principles to prevent severe disease. Journal of the neurological sciences, 426, 117463. Advance online publication. https://doi.org/10.1016/j.jns.2021.117463
Publication Title
Journal of the neurological sciences
DOI
10.1016/j.jns.2021.117463
Academic Level
faculty
Mentor/PI Department
Neurology
Comments
Copyright © 2021 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.